DTE
38
-4
CMCSA
44
-2
ACN
56
2
DGX
35
2
BF.B
48
-2
RCL
68
4
PM
49
2
MTCH
59
9
F
59
3
FSLR
73
15
STX
69
2
TRIP
49
2
KR
37
-5
HCA
64
5
XEL
37
-2
DD
45
-7
IR
58
3
GM
85
2
HSY
43
2
COP
47
3
DTE
38
-4
CMCSA
44
-2
ACN
56
2
DGX
35
2
BF.B
48
-2
RCL
68
4
PM
49
2
MTCH
59
9
F
59
3
FSLR
73
15
STX
69
2
TRIP
49
2
KR
37
-5
HCA
64
5
XEL
37
-2
DD
45
-7
IR
58
3
GM
85
2
HSY
43
2
COP
47
3
Financhill
Back

Rayliant Quantitative Developed Market Equity ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
50

RAYD
Rayliant Quantitative Developed Market Equity ETF

Last Price:
$37.55
Seasonality Move:
3.83%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
50
Rayliant Quantitative Developed Market Equity ETF (RAYD) is a Sell

Is Rayliant Quantitative Developed Market Equity ETF a Buy, Sell or Hold?

  • The current Rayliant Quantitative Developed Market Equity ETF [RAYD] share price is $38.45. The Score for RAYD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RAYD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RAYD Stock Price Chart

What is Rayliant Quantitative Developed Market Equity ETF's stock price today?

  • The Rayliant Quantitative Developed Market Equity ETF share price today is $38.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing buying pressure, which is a positive indicator for future bullish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

RAYD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.16 Buy
Relative Strength Index (14 RSI): 57.19 Buy
Chaikin Money Flow: 1597 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.92 - 38.22) Buy
Bollinger Bands (100): (36.76 - 37.96) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.79 Sell
Chaikin Money Flow: 9780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.35) Sell
Bollinger Bands (100): (12.23 - 15.15) Sell

RAYD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.19 Buy
20-day SMA: 37.68 Buy
50-day SMA: 37.59 Buy
200-day SMA: 35.63 Buy
8-day EMA: 20.15 Buy
20-day EMA: 9.86 Buy
50-day EMA: 4.3 Buy
200-day EMA: 1.12 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 11.62 Sell
50-day SMA: 12.8 Sell
200-day SMA: 11.89 Sell
8-day EMA: 11.86 Sell
20-day EMA: 11.96 Sell
50-day EMA: 12.6 Sell
200-day EMA: 12.22 Sell

Rayliant Quantitative Developed Market Equity ETF Earnings Growth & RAYD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Rayliant Quantitative Developed Market Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):